AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Primary Health Properties PLC

Notice of Dividend Amount Nov 19, 2019

4780_rns_2019-11-19_be6cb0cc-69e9-4e69-939e-7008f957d6f0.html

Notice of Dividend Amount

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9598T

Primary Health Properties PLC

19 November 2019

Primary Health Properties PLC

("PHP" or the "Company")

In connection with the scrip dividend offer made in respect of the fourth quarterly interim dividend for 2019 of 1.40 pence per ordinary share announced on 3 October 2019 ("Scrip Offer"), the Company announces that it has received valid elections from shareholders holding a total of 192,481,003 ordinary shares of 12.5p each in the capital of the Company ("Ordinary Shares") resulting in a requirement to issue 1,908,300 new Ordinary Shares ("New Shares").  

PHP has therefore made application for the New Shares to be issued in connection with the Scrip Offer to be admitted to the premium segment of the Official List of the Financial Conduct Authority and to trading on the main market for listed securities of the London Stock Exchange respectively.  Admission of the New Shares is expected to be effective on 22 November 2019.

For further information:

Primary Health Properties PLC

Paul Wright, Nexus Management Services Limited, Company Secretary                                              +44(0) 20 7451 7050

LEI: 213800Y5CJHXOATK7X11

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

MSCUKUNRKNAAAAA

Talk to a Data Expert

Have a question? We'll get back to you promptly.